Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 of its pivotal ApproaCH Trial of TransCon CNP (navepegritide) in children ...

This year, the INTA Annual Meeting lands in sunny San Diego, California—a city known not only for its breathtaking coastline, ...